PMID- 18025130 OWN - NLM STAT- MEDLINE DCOM- 20071214 LR - 20211020 IS - 1540-9538 (Electronic) IS - 0022-1007 (Print) IS - 0022-1007 (Linking) VI - 204 IP - 12 DP - 2007 Nov 26 TI - A viral CTL escape mutation leading to immunoglobulin-like transcript 4-mediated functional inhibition of myelomonocytic cells. PG - 2813-24 AB - Viral mutational escape can reduce or abrogate recognition by the T cell receptor (TCR) of virus-specific CD8+ T cells. However, very little is known about the impact of cytotoxic T lymphocyte (CTL) epitope mutations on interactions between peptide-major histocompatibility complex (MHC) class I complexes and MHC class I receptors expressed on other cell types. Here, we analyzed a variant of the immunodominant human leukocyte antigen (HLA)-B2705-restricted HIV-1 Gag KK10 epitope (KRWIILGLNK) with an L to M amino acid substitution at position 6 (L6M), which arises as a CTL escape variant after primary infection but is sufficiently immunogenic to elicit a secondary, de novo HIV-1-specific CD8+ T cell response with an alternative TCR repertoire in chronic infection. In addition to altering recognition by HIV-1-specific CD8+ T cells, the HLA-B2705-KK10 L6M complex also exhibits substantially increased binding to the immunoglobulin-like transcript (ILT) receptor 4, an inhibitory MHC class I-specific receptor expressed on myelomonocytic cells. Binding of the B2705-KK10 L6M complex to ILT4 leads to a tolerogenic phenotype of myelomonocytic cells with lower surface expression of dendritic cell (DC) maturation markers and co-stimulatory molecules. These data suggest a link between CTL-driven mutational escape, altered recognition by innate MHC class I receptors on myelomonocytic cells, and functional impairment of DCs, and thus provide important new insight into biological consequences of viral sequence diversification. FAU - Lichterfeld, Mathias AU - Lichterfeld M AD - Partners AIDS Research Center, Massachusetts General Hospital, and Harvard University Center for AIDS Research, Boston, MA 02129, USA. FAU - Kavanagh, Daniel G AU - Kavanagh DG FAU - Williams, Katie L AU - Williams KL FAU - Moza, Beenu AU - Moza B FAU - Mui, Stanley K AU - Mui SK FAU - Miura, ToshiYuki AU - Miura T FAU - Sivamurthy, Rohini AU - Sivamurthy R FAU - Allgaier, Rachel AU - Allgaier R FAU - Pereyra, Florencia AU - Pereyra F FAU - Trocha, Alicja AU - Trocha A FAU - Feeney, Margaret AU - Feeney M FAU - Gandhi, Rajesh T AU - Gandhi RT FAU - Rosenberg, Eric S AU - Rosenberg ES FAU - Altfeld, Marcus AU - Altfeld M FAU - Allen, Todd M AU - Allen TM FAU - Allen, Rachel AU - Allen R FAU - Walker, Bruce D AU - Walker BD FAU - Sundberg, Eric J AU - Sundberg EJ FAU - Yu, Xu G AU - Yu XG LA - eng GR - F32 AI058457/AI/NIAID NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20071119 PL - United States TA - J Exp Med JT - The Journal of experimental medicine JID - 2985109R RN - 0 (HLA-B27 Antigen) RN - 0 (Histocompatibility Antigens Class I) RN - 0 (Receptors, Antigen, T-Cell) SB - IM CIN - J Exp Med. 2007 Nov 26;204(12):2785-8. PMID: 18025124 MH - Acquired Immunodeficiency Syndrome/genetics/*immunology MH - CD8-Positive T-Lymphocytes/*immunology/*virology MH - HIV/genetics/*immunology MH - HIV Infections/*immunology MH - HLA-B27 Antigen/genetics MH - Histocompatibility Antigens Class I/genetics MH - Humans MH - Monocytes/*immunology/virology MH - Mutation MH - Myeloid Cells/*immunology/virology MH - Receptors, Antigen, T-Cell/genetics MH - T-Lymphocytes, Cytotoxic/*immunology/*virology PMC - PMC2118510 EDAT- 2007/11/21 09:00 MHDA- 2007/12/15 09:00 PMCR- 2008/05/26 CRDT- 2007/11/21 09:00 PHST- 2007/11/21 09:00 [pubmed] PHST- 2007/12/15 09:00 [medline] PHST- 2007/11/21 09:00 [entrez] PHST- 2008/05/26 00:00 [pmc-release] AID - jem.20061865 [pii] AID - 20061865 [pii] AID - 10.1084/jem.20061865 [doi] PST - ppublish SO - J Exp Med. 2007 Nov 26;204(12):2813-24. doi: 10.1084/jem.20061865. Epub 2007 Nov 19.